Literature DB >> 20461450

Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Nathan J Godde1, Ryan C Galea, Imogen A Elsum, Patrick O Humbert.   

Abstract

Epithelial to mesenchymal transition (EMT) and its reversion via mesenchymal to epithelial transition (MET), represent a stepwise cycle of epithelial plasticity that allows for normal tissue remodelling and diversification during development. In particular, epithelial-mesenchymal plasticity is central to many aspects of mammary development and has been proposed to be a key process in breast cancer progression. Such epithelial-mesenchymal plasticity requires complex cellular reprogramming to orchestrate a change in cell shape to an alternate morphology more conducive to migration. During this process, epithelial characteristics, including apical-basal polarity and specialised cell-cell junctions are lost and mesenchymal properties, such as a front-rear polarity associated with weak cell-cell contacts, increased motility, resistance to apoptosis and invasiveness are gained. The ability of epithelial cells to undergo transitions through cell polarity states is a central feature of epithelial-mesenchymal plasticity. These cell polarity states comprise a set of distinct asymmetric distributions of cellular constituents that are fashioned to allow specialized cellular functions, such as the regulated homeostasis of molecules across epithelial barriers, cell migration or cell diversification via asymmetric cell divisions. Each polarity state is engineered using a molecular toolbox that is highly conserved between organisms and cell types which can direct the initiation, establishment and continued maintenance of each asymmetry. Here we discuss how EMT pathways target cell polarity mediators, and how this EMT-dependent change in polarity states impact on the various stages of breast cancer. Emerging evidence places cell polarity at the interface of proliferation and morphology control and as such the changing dynamics within polarity networks play a critical role in normal mammary gland development and breast cancer progression.

Entities:  

Mesh:

Year:  2010        PMID: 20461450     DOI: 10.1007/s10911-010-9180-2

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  238 in total

1.  PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex.

Authors:  T Yamanaka; Y Horikoshi; A Suzuki; Y Sugiyama; K Kitamura; R Maniwa; Y Nagai; A Yamashita; T Hirose; H Ishikawa; S Ohno
Journal:  Genes Cells       Date:  2001-08       Impact factor: 1.891

Review 2.  Mechanisms of asymmetric cell division: flies and worms pave the way.

Authors:  Pierre Gönczy
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

Review 3.  Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.

Authors:  Jane E Visvader
Journal:  Genes Dev       Date:  2009-11-15       Impact factor: 11.361

4.  The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer.

Authors:  Marissa E Nolan; Victoria Aranda; Sangjun Lee; Balasubramanian Lakshmi; Srinjan Basu; D Craig Allred; Senthil K Muthuswamy
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

5.  Cdc42, Par6, and aPKC regulate Arp2/3-mediated endocytosis to control local adherens junction stability.

Authors:  Marios Georgiou; Eliana Marinari; Jemima Burden; Buzz Baum
Journal:  Curr Biol       Date:  2008-10-30       Impact factor: 10.834

Review 6.  Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.

Authors:  Michèle Sabbah; Shahin Emami; Gérard Redeuilh; Sylvia Julien; Grégoire Prévost; Amazia Zimber; Radia Ouelaa; Marc Bracke; Olivier De Wever; Christian Gespach
Journal:  Drug Resist Updat       Date:  2008-08-20       Impact factor: 18.500

7.  Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.

Authors:  Els C Robanus-Maandag; Cathy A J Bosch; Petra M Kristel; Augustinus A M Hart; Ian F Faneyte; Petra M Nederlof; Johannes L Peterse; Marc J van de Vijver
Journal:  J Pathol       Date:  2003-09       Impact factor: 7.996

8.  Rho-kinase phosphorylates PAR-3 and disrupts PAR complex formation.

Authors:  Masanori Nakayama; Takaaki M Goto; Masayuki Sugimoto; Takashi Nishimura; Takafumi Shinagawa; Sigeo Ohno; Mutsuki Amano; Kozo Kaibuchi
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

9.  Cdc42 and Par proteins stabilize dynamic adherens junctions in the Drosophila neuroectoderm through regulation of apical endocytosis.

Authors:  Kathryn P Harris; Ulrich Tepass
Journal:  J Cell Biol       Date:  2008-12-08       Impact factor: 10.539

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  42 in total

1.  Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.

Authors:  Tarso Felipe Teixeira; Luciana Boffoni Gentile; Tereza Cristina da Silva; Gregory Mennecier; Lucas Martins Chaible; Bruno Cogliati; Marco Antonio Leon Roman; Marco Antonio Gioso; Maria Lucia Zaidan Dagli
Journal:  Vet Res Commun       Date:  2013-10-15       Impact factor: 2.459

Review 2.  Mechanisms of cell polarity and aquaporin sorting in the nephron.

Authors:  Bayram Edemir; Hermann Pavenstädt; Eberhard Schlatter; Thomas Weide
Journal:  Pflugers Arch       Date:  2011-02-16       Impact factor: 3.657

Review 3.  Endomembrane control of cell polarity: Relevance to cancer.

Authors:  Francesco Baschieri; Hesso Farhan
Journal:  Small GTPases       Date:  2015

Review 4.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

5.  CPEB1 promotes differentiation and suppresses EMT in mammary epithelial cells.

Authors:  Ewa Grudzien-Nogalska; Brent C Reed; Robert E Rhoads
Journal:  J Cell Sci       Date:  2014-03-14       Impact factor: 5.285

Review 6.  RhoGTPase-binding proteins, the exocyst complex and polarized vesicle trafficking.

Authors:  Debarati Mukherjee; Arpita Sen; R Claudio Aguilar
Journal:  Small GTPases       Date:  2014-06-10

7.  Epithelial-mesenchymal transition during extravillous trophoblast differentiation.

Authors:  Jessica E Davies; Jürgen Pollheimer; Hannah E J Yong; Maria I Kokkinos; Bill Kalionis; Martin Knöfler; Padma Murthi
Journal:  Cell Adh Migr       Date:  2016-04-12       Impact factor: 3.405

8.  β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.

Authors:  Tung Bui; Babette Schade; Robert D Cardiff; Olulanu H Aina; Virginie Sanguin-Gendreau; William J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 9.  Claudins in morphogenesis: Forming an epithelial tube.

Authors:  Amanda I Baumholtz; Indra R Gupta; Aimee K Ryan
Journal:  Tissue Barriers       Date:  2017-08-24

10.  TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.

Authors:  Yoshiho Ikeuchi; Shorafidinkhuja Dadakhujaev; Amrita S Chandhoke; Mai Anh Huynh; Anna Oldenborg; Mikako Ikeuchi; Lili Deng; Eric J Bennett; J Wade Harper; Azad Bonni; Shirin Bonni
Journal:  J Biol Chem       Date:  2014-07-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.